AEON Biopharma (AEON) stock: insider trades, news & valuation
Health Care · Net buyingShare price and insider trades
AEON Biopharma insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $242K and 0 sold $0 of AEON stock on the open market.
Get emailed when insiders cluster-buy stocks like AEON
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
AEON insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $242K | 1 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 AEON Biopharma, Inc. insider reported open-market purchases totaling $242K, while 0 insiders reported sales totaling $0.
AEON earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 12, 2026 | +5.0% | None | -0.7%S&P +0.9% | +20.7% |
| May 14, 2026 | -16.7% | None | -12.0%S&P -0.4% | -1.0% |
| Mar 30, 2026 | -0.9% | None | -15.1%S&P +2.6% | -6.3% |
| Nov 14, 2025 | +6.8% | None | -7.4%S&P -0.9% | +11.5% |
| Aug 12, 2025 | -16.8% | None | +21.8%S&P +1.4% | -2.5% |
| May 14, 2025 | +19.5% | None | -1.8%S&P +0.6% | +84.8% |
| Mar 24, 2025 | -5.6% | None | +0.1%S&P +2.0% | -31.4% |
| Nov 13, 2024 | -24.9% | None | -18.5%S&P -0.6% | +10.1% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
AEON news sentiment trend
Weekly headline tone (positive minus negative headlines) over 13 weeks. Green dots mark weeks with insider buying.
Tone is scored from headline wording only. It describes the news, not where the stock is going.
AEON stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
- Positive Biotech Stocks Surge - NIVF +124 %, CNTB +124 %, SGMT +9 %, VBIO +12 %, AEON · rttnews.com
- 8-K Investor disclosure, Other material event
- Positive Policy Aeon Biopharma Jumps 19 % on FDA Feedback - Orange County Business Journal · ocbj.com
- 8-K Earnings release, Investor disclosure
- 8-K Investor disclosure, Other material event
- 8-K Other material event
- 8-K Material agreement, Other material event
- 8-K Shareholder vote results
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 21SEC | Timothy P Lynch10% Owner | Buy | 1,150,0006,500,000 held (+21%) | $0.21 | $242K | +31.4% | — |
Insiders at AEON Biopharma, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Timothy P Lynch10% Owner | $242K | — | Aug 21, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
AEON stock: common questions
Are AEON Biopharma, Inc. insiders buying AEON stock?
In the past 12 months, 1 insiders reported open-market purchases of AEON worth $242K. The latest was 10% Owner Timothy P Lynch bought $242K of AEON at $0.21 — first open-market purchase in our records; raises the stake by 21%.
Are AEON Biopharma, Inc. insiders selling AEON stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is AEON's 52-week range?
Over the past year AEON has traded between $0.19 and $1.40. It last closed at $0.28 on Oct 9, 2026.